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Abstract
Background: Despite the potentially life-saving benefits of the implantable cardioverter-
defibrillator (ICD), a significant group of patients experiences emotional distress after ICD
implantation. Different psychosocial interventions have been employed to improve this condition,
but previous reviews have suggested that methodological issues may limit the validity of such
interventions. Aim: To review the methodology of previously published studies of psychosocial
interventions in ICD patients, according to CONSORT statement guidelines for non-
pharmacological interventions, and provide recommendations for future research.
Methods: We electronically searched the PubMed, PsycInfo and Cochrane databases. To be
included, studies needed to be published in a peer-reviewed journal between 1980 and 2008, to
involve a human population aged 18+ years and to have an experimental design.
Results: Twelve studies met the eligibility criteria. Samples were generally small. Interventions
were very heterogeneous; most studies used cognitive behavioural therapy (CBT) and exercise
programs either as unique interventions or as part of a multi-component program. Overall, studies
showed a favourable effect on anxiety (6/9) and depression (4/8). CBT appeared to be the most
effective intervention. There was no effect on the number of shocks and arrhythmic events,
probably because studies were not powered to detect such an effect. Physical functioning improved
in the three studies evaluating this outcome. Lack of information about the indication for ICD
implantation (primary vs. secondary prevention), limited or no information regarding use of anti-
arrhythmic (9/12) and psychotropic (10/12) treatment, lack of assessments of providers' treatment
fidelity (12/12) and patients' adherence to the intervention (11/12) were the most common
methodological limitations.
Conclusions: Overall, this review supports preliminary evidence of a positive effect of
psychosocial interventions on anxiety and physical functioning in ICD patients. However, these
initial findings must be interpreted cautiously because of important methodological limitations.
Future studies should be designed as large RCTs, whose design takes into account the specific
challenges associated with the evaluation of behavioural interventions.
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Background
Implantable cardioverter-defibrillators (ICD)[1] are elec-
tronic devices used to prevent sudden cardiac death and to
treat severe ventricular arrhythmias. Primary and second-
ary prevention trials have consistently shown that ICDs
reduce the risk of cardiac death [2-6], making them the
first-choice treatment for patients at risk of sudden cardiac
death. Since the approval of ICDs by the Food and Drug
Administration in 1985, the number of ICD implanta-
tions performed in the United States has steadily
increased. The estimated number of hospitalizations for
ICD implantation increased from 5,600 in 1990 to
108,680 in 2005, and the estimated annual rate of hospi-
talizations increased tenfold [7].
Despite the proven efficacy of ICDs, concerns have been
raised regarding quality of life and psychological well-
being of recipients of an ICD [8,9]. There are a number of
stressors that can cause significant psychological discom-
fort [10] and consequently affect the quality of life of an
ICD recipient. A substantial amount of anxiety is related
to the shocks: patients are afraid of the pain caused by a
shock[11] and of the circumstances related to the unpre-
dictability of its occurrence, such as the possibility of
receiving a shock while out of the house, or the reaction
of bystanders not familiar with the patient or the
ICD[12,13]. A further source of concern is the possible
failure of the ICD, including concern that the system will
not be able to control the dysrhythmia or concern about
depending upon an electronic device for survival[13]
Although many ICD patients adapt to the device over
time, some degree of anxiety is experienced by 24% to
87% of patients, and a significant proportion (13% to
38%) experience symptoms compatible with a diagnosis
of anxiety disorder [9].
Anxiety and depression have been shown to be independ-
ent predictors of mortality in ischemic heart disease [14-
20], raising the possibility that anxiety plays a contribut-
ing role in the high one-year mortality rate observed after
ICD implantation [6] despite the effectiveness of the ICD
in preventing sudden death. Paradoxically, ICD patients
might be at higher risk of having arrhythmias, and there-
fore of receiving shocks, because of their fear of receiving
shocks. The role of anxiety and stress in inducing ventricu-
lar arrhythmias has been hypothesized since the 1970s
[21,22] and in the 1990s evidence indicated that strong
emotions can precipitate cardiac events [23-25]. Emo-
tional [26,27] and mental stress[28] were shown to have
a detrimental effect on both cardiac perfusion and func-
tion. This suggests that, at least in some settings, negative
emotions may play a causal role in cardiac events, rather
than being secondary phenomena. Anxiety may worsen
cardiac outcomes by reducing heart rate variability (HRV)
[29,30] and baro-reflex control[31] or by inducing altera-
tions in the coagulation system [32]. Conversely, condi-
tions promoting psychological well-being such as social
support or pet ownership [33,34] may favourably influ-
ence variables such as HRV and survival.
Considering the negative impact of anxiety and depres-
sion on cardiac outcomes, over the past ten years consid-
erable effort has been invested in designing interventions
that can improve psychological wellbeing in ICD recipi-
ents. Preliminary evidence suggests that these interven-
tions may be effective; however, most literature reviews,
including recent ones [35-37] did not address many meth-
odological issues related to the non-pharmacological
nature of the intervention(s).
The aims of this review was to examine the methodology
of previously published studies of psychosocial interven-
tions in patients receiving an ICD, using the CON-
SORT[38] statement for non-pharmacological
interventions as a guideline, and to provide recommenda-
tions for future research.
Methods
We performed an electronic search of the databases
PubMed, Cochrane, and PsychInfo using combinations of
these terms: ICD, implantable cardioverter defibrillator,
cardioverter defibrillator, implantable defibrillator, defi-
brillator, automatic defibrillator, intervention, treatment,
rehabilitation, therapy, psychological, psychosocial,
behavioural, depression, depressive disorder, anxiety,
anxiety disorder, and quality of life.
To be included studies had to meet these criteria: 1) pub-
lication in a peer-reviewed journal after 1980, 2) include
adult humans (≥18 years old), and 3) have an experimen-
tal design. Criterion 1 was chosen since the first ICD was
implanted in 1980. Randomized clinical trials (RCT),
quasi-randomized, and quasi-experimental studies were
included.
We defined "psycho-social" as any non-pharmacological
intervention aimed at improving the psychological well-
being of ICD patients. Thus, our sample included studies
evaluating interventions that were not strictly psychologi-
cal, such as educational interventions, support groups,
and cardiac rehabilitation. Studies evaluating the effect of
mixed interventions (i.e., psychological intervention or
support group combined with an exercise program) were
also included. Literature reviews, case reports, and obser-
vational studies were excluded. In addition to the elec-
tronic search, reference lists of included articles and
literature reviews were hand searched. The first author
conducted the computer search; after eliminating double
hits, both authors reviewed the abstracts for eligibility. We
resolved any disagreement until we reached consensus.
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An original data abstraction form was designed to collect
information relevant to this review, using the CONSORT
Statement Extension for Trials Assessing Non-pharmaco-
logic Treatments [39,40] as a guideline. Due to the heter-
ogeneous nature of the interventions and of the
populations studied, a meta-analysis was not conducted.
Results
Study selection
Our search initially identified 927 titles: 583 from
PubMed, 222 from Cochrane, and 122 from PsychInfo.
After applying the inclusion criteria, 506 titles were
excluded. Removing 54 double hits left 367 studies. After
title review, 320 articles were excluded because the study
topic was not pertinent to this review, leaving 47 articles
for abstract review. Another four articles were included
after hand searching the reference lists of literature
reviews. The literature selection process is summarized in
Figure 1. Of the 51 articles whose abstracts were reviewed,
38 were excluded: 25 had a non-experimental design, one
involved cardiac arrest survivors who did not receive an
ICD, ten were literature reviews or editorials, and two
lacked a comparison group.
The sample for review included 13 papers, of which two
[41,42] reported on the same sample at different follow-
up times and were considered one study. Twelve studies
were thus included in this analysis (Additional File 1).
In this section, we will describe the included studies, sum-
marize the population characteristics, and review the
study interventions. We will then briefly describe the
main statistical methods used, and summarize the inter-
vention effects on psychological and cardiac outcomes.
Flow-chart of literature selection processigure 1
Flow-chart of literature selection process.
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Characteristics of the included studies
Study design
Of the 12 studies reviewed, nine adopted a randomized
controlled trial (RCT) design [41-50]; one study used a
cluster RCT design [48], and two adopted a cross-over RCT
design [46,47] (Additional File 1). In one study, patients
were randomized before being asked to participate [51].
In the two non-randomized studies [52,53], the compari-
son group included patients unable to participate due to
lack of transportation or illness.
Recruiting centres were teaching hospitals [43-45,49-52],
or tertiary referral centres [41,46-48,53]. Recruitment
duration was not reported in seven studies [44-
47,49,52,53]; in the remaining studies [41,43,48,50,51] it
ranged from 10 to 23 months. Recruitment information
was often incomplete: some studies did not specify eligi-
bility criteria [43,51,52], and others did not report the
number of screened and/or eligible patients [41,43,45-
47,49-53]. In the three studies specifying the number of
eligible subjects, the proportions of patients who refused
or were unable to participate were 15% [48], 65% [44],
and 46% [47]. Lack of transportation or distance from
study site was the most frequent reason for not being able
to participate [45,47,52]. A flow diagram describing the
progress of participants through the different phases of a
RCT as recommended by the CONSORT statement [54]
was included only in three studies [44,47,48].
Sample Size
Sample sizes were small (range 12-192) in most studies;
in seven, the intervention or control arm had less than 20
participants.
Follow-up period
The duration of follow up varied from 1 to 12 months. In
fifty percent of the studies, the follow up period was
between 3 and 6 months.
Retention rates
Seven studies reported the number of dropouts (Addi-
tional File 1). One-year retention rates ranged from 57%
[44] to 89% [42]; the study reporting the highest retention
rate offered monetary compensation to participants. In
studies with shorter (3-6 months) follow-ups, retention
rates varied from 66% to 95%.
Study Samples
Study samples (Additional File 2) were predominantly
male (65% to 91%). In the four studies reporting racial
distribution [41,48,49,51], Caucasians were the most
highly represented group (77% to 98%). Most studies
excluded patients younger than 18 or 21; the mean age
varied from 58 to 66 years (range 28-83). Six studies
enrolled only new ICD recipients [41,43,45,48,50,51];
one included both new and old recipients [44], and five
enrolled old recipients only [46,47,49,52,53]. In the stud-
ies enrolling old recipients, mean time since initial
implantation varied considerably, from 8 months (12.5 in
the intervention group) [52] to 20 months (range 7-53)
[46]. One study reported that 55% and 45% of partici-
pants were enrolled 5-6 months and 12-24 months post-
ICD, respectively (52) and in two studies (38, 48) time
since implantation was not reported.
The indication for ICD implantation or the underlying
cardiac disease was not reported in most studies. The most
common cardiac diagnosis was coronary artery disease
(up to 69% of the population) [41,44,46,48,49]. Details
about the type of ICD implanted were also missing; in one
study [50] 50% of study participants had their ICD
implanted using thoracotomy, a more invasive procedure
than that currently used. Other studies [52,53] conducted
during the same period (late 1980s-early 1990s) do not
report the use of thoracotomy, but they might have
included such patients. Mean ejection fraction (EF), when
reported, was between 30% and 44% [41,44,46,50,52].
Information about New York Heart Association (NYHA)
functional class was provided in two studies only: in one
study the mean NYHA class was 1.6 and 2.0 in the inter-
vention and control groups, respectively; in the second
study [48] 75% of subjects were in NYHA class I or II. Col-
lecting data on these variables both at baseline and during
follow-up, and adjusting for them in the analysis is impor-
tant because a worsening of underlying cardiac function
can affect study outcomes. Similarly, information about
important confounders such as the concurrent use of anti-
arrhythmic and psychotropic drugs was not available in
most studies. However, 15% to 20% of patients were
reported to have received psychotropic drugs during two
studies [49,48].
Interventions
Details about the characteristics of the interventions are
reported in Additional File 3. Interventions were
extremely diverse; some studies used multi-component
interventions [46-50], and others employed mono-com-
ponent interventions (support groups [52,53], phone
support [41], cognitive-behavioural (CBT) therapy
[44,51], or educational interventions [43,45]. CBT was a
core intervention component in six studies [44,46-49,51].
CBT was self-administered in one study [48], and special-
ist-delivered as a group intervention in the other studies.
Kohn [51] employed one-to-one meetings; in another
study [46] one-to-one CBT was available only to patients
with high levels of anxiety.
In most studies, interventions were supplemented with
relaxation techniques taught during sessions or self-taught
by tape [44,46-48,50]. In three studies [46-48], patients
were also involved in an aerobic exercise program as part
of a multi-component intervention. The duration of inter-
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ventions ranged widely, from 2 [45] to 20 weeks [51]; it
was not reported in three studies[43,48,53]
The control condition was represented as "usual care" in
eight studies, was not reported in two studies[52,53], and
was described as "no therapy" in another [51]. Sears et al.
reported delivering a shorter version of the intervention
(one-day workshop in addition to usual care for ethical
reasons [49]. Only eight studies reported what "usual
care" entailed (48, 50, 52-54, 56-58); patients receiving
"usual care" were exposed to very different procedures
(Additional File 3).
Significant others were involved either as co-participants
or because they were invited to attend study sessions in
seven studies [43,45,46,50-53].
No study provided details about standardization of inter-
vention delivery, i.e., attached scripts of the phone conver-
sations or support meetings. As in most behavioural
interventions, blinding of participants was impossible;
attempts to blind outcome assessors or care providers not
involved in the study were not mentioned. Information
about adherence to study interventions, such as attend-
ance at meetings or support groups, was not available
except in Badger [52] (attendance at study meetings of
87.5%), while no study assessed treatment fidelity.
Statistical analyses
In most studies, primary outcomes were not clearly speci-
fied. Of the ten studies using a RCT design, only three
[41,44,48] used an "intention to treat" approach, of
which one was a "modified" intention to treat [41] and
one was used only for the primary outcome [44].
Repeated-measures ANOVA was used in most studies, and
psychological outcomes were usually analyzed as contin-
uous variables. Most studies reported no baseline differ-
ences between intervention and control groups for major
demographic and co-morbidity covariates, but sample
sizes were small. Only three studies [41,44,48] specified
whether the final model was adjusted for covariates such
as age, baseline outcome measures, use of psychotropic
and anti-arrhythmic medications, EF and NYHA class, and
time from ICD implantation. Power calculations were
reported in three studies only [41,44,48].
Psychological Outcomes
The effect of the intervention on anxiety [41,42,44-
49,51,53] and depression [41,42,44-49,51] was assessed
in all but three [50,52] studies (Additional File 4), and it
was measured by self-administered questionnaires. Anxi-
ety was most frequently measured by the Hospital Anxiety
and Depression Scale (HADS) [46-48], and the State-Trait
Anxiety Inventory (STAI);[41,49,51,53]. Depression was
most often measured by the Beck Depression Inventory
(BDI), [44,51] the Center for Epidemiological Studies
Depression Scale (CES-D),[41,49] and the HADS [46-48].
Although studies sometimes used the same instrument,
different outcomes were often evaluated. For example,
some studies compared mean pre/post intervention
scores within groups [41,46,53], while others compared
mean pre/post intervention changes in HADS anxiety
scores between groups [47], mean STAI anxiety scores
between groups [51], or the change in the proportions of
patients with HADS scores indicating significant anxiety
[48]. Kohn [51] evaluated both STAI trait-anxiety and
state-anxiety scores, while others [41,49,53] focused on
state anxiety only.
Anxiety
Details about the impact of interventions on anxiety are
presented in Additional File 4. Overall, of nine studies
evaluating the impact on anxiety, six [44,46-49,51]
showed a significant positive effect, while three [42,45,53]
showed no improvement. In the two studies that meas-
ured psychological outcomes other than anxiety, one [52]
reported no improvement in psychological adjustment,
and another [50] reported no differences in the mood
state profile at 4 months; both used a support-group inter-
vention. All studies showing a positive effect included
CBT either as the only intervention [51] or an element of
a multi-component intervention [44,46-49]. The three
studies showing no effect were either purely educational
programs [45] or support interventions [41,53].
Biological markers of stress (salivary cortisol) and inflam-
matory markers (TNFα and IL-6) were included as out-
come measures in one study (38). Salivary cortisol
decreased significantly over time in both groups, while
inflammatory markers did not change significantly.
Depression
Depression was a study outcome in eight studies, and only
four ([46-48,51]) showed an effect. Fitchet ([46]) found a
reduction in mean HADS depression scores from pre to
post-rehabilitation in the intervention group (9.9 to 6.7 p
< 0.001), while scores increased in the control group; in
Frizelle study ([47]), HADS depression scores decreased
significantly post vs. pre-treatment. Kohn ([51]) reported
a decrease in BDI depression scores in the intervention
group (6.9 ± 5.9 vs. 15.0 ± 13, but baseline depression
scores were not reported. Lewin ([48]) found a reduction
in the proportion of patients with HADS scores > 8 (prob-
able significant clinical depression) in the intervention vs.
the control group (-13% vs. -2.1%). Interestingly, of the
four studies showing an effect on depression, three
included an exercise component.([46-48])
Cardiac Outcomes
Half the studies (Additional File 5) included cardiac out-
comes: shocks in six studies [41,44,46-48,51]; sustained
ventricular tachycardia (VT) requiring pacing for termina-
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tion in two [46,47], and ICD storms in one study [48].
Two studies [42,48] also evaluated the effect of the inter-
vention on the number of hospitalizations and visits, and
three [46-48] included exercise capacity. In the only study
with HRV as an outcome [44], two indicators of auto-
nomic tone improved, supporting the conclusion that the
intervention improved adrenergic/vagal balance.
Shocks and heart rate variability
No study showed a significant effect on shocks. At 1 year
of follow up, Chevalier [44] showed a non- significant
reduction in the number of patients receiving a shock (3
in intervention vs. 6 in control group) and a reduction in
shock rate and in use of beta-blockers and other anti-
arrhythmic drugs in the intervention group (post-hoc
analysis). Similarly, Lewin [48] showed a non-significant
difference in the proportion of patients receiving shocks
(9.5% vs. 13%) and ICD storms (1.6 vs. 4.8) at six months
of follow-up. The mean number of shocks was similar in
both groups.
Physical functioning
Physical functioning, measured as exercise capacity,
improved significantly in three studies after a comprehen-
sive cardiac rehabilitation (CCR) or ICD plan [46-48]. In
one study [46], the pre- to post-intervention exercise time
on a symptom-limited treadmill test increased 16% (p <
0.001) in the intervention group, but did not change in
the usual care group. Frizelle et al. [47] found a significant
improvement in level of difficulty (mean change pre-post
intervention 1.37 vs. 0, p = 0.050) and the distance
walked (mean change 85.6 vs. 0.32, p= 0.010) on a shuttle
test. In another study [48], the Seattle angina scores of
patients enrolled in the CCR improved significantly (dif-
ference in favour of intervention: 2.22, CI 0.11,7.22).
Hospitalizations
The two studies evaluating the impact on health care use
yielded conflicting results. Dougherty [41,42] did not find
any difference in the number of ER admissions, hospital-
izations or clinic visits at 1 year, while Lewin [48] reported
a significant reduction in the mean number of emergency
admissions at 6 months (0.39 vs. 0.11, p = 0.05) and no
differences in outpatients visits or routine admissions.
Discussion
Efficacy of the Interventions
Overall, the results of this review support previous, pre-
liminary evidence [36] of a positive effect of psychosocial
interventions in ICD patients. Two-thirds of the studies
showed a favourable effect on anxiety, and half reduced
depression. CBT seems to be the most effective interven-
tion on anxiety, since all studies showing a positive effect
included CBT either as the only intervention [51] or as an
element of a multi-component intervention [44,46-49].
Three studies showing a positive effect on depression
included an exercise component [46-48]. No evidence
was found for a positive effect of psychosocial interven-
tions on the number of shocks and arrhythmic events,
probably due to the low frequency of shocks and short fol-
low-up periods, and because most studies were not suffi-
ciently powered to detect these outcomes. Only one study
[44] documented an effect of the intervention (CBT) on
heart rate variability; interestingly, the positive effect on
adrenergic/vagal balance did not result in a reduction of
arrhythmic episodes or shocks. Findings on physical func-
tioning are promising, while only Lewin [48] showed an
impact of the intervention on the use of health care facil-
ities. Most studies used anxiety and depression scores as
continuous variables, and generally showed a modest
improvement in anxiety or depression scores, whose clin-
ical significance has yet to be determined.
Methodological limitations
Both positive and negative findings should be weighed
against methodological limitations, which affected, to
some degrees, most of the studies.
Randomization
The purpose of randomization is to reduce selection bias,
i.e. the uneven distribution of prognostic factors between
the experimental group and the control group. Randomi-
zation reduces selection bias by creating comparison
groups with similar characteristics regarding known and
unknown confounders. Twenty-five percent of studies
were not randomized or did not perform a correct rand-
omization. Non-random allocation can lead to overesti-
mation as well as underestimation of treatment
effects[55].
Study Samples
Study samples were generally small and heterogeneous. A
small sample size limits the power to detect an effect, and
increases the chances that important prognostic factors
will differ between the intervention and the control
group, even when randomization has been adequately
performed.
Measures
Psychological outcomes were determined by self-adminis-
tered questionnaires, and an objective evaluation of the
outcome was lacking. Most studies used anxiety and
depression scores as continuous variables, and generally
showed a modest improvement in anxiety or depression
scores, whose clinical significance has yet to be deter-
mined. Some scales have cut-off scores for defining prob-
ably mild, moderate, or severe depression/anxiety[56].
Thus, the numbers of individuals with anxiety/depression
scores above these cut-offs would be more clinically
meaningful study outcomes [48].
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Interventions
Interventions were extremely different and even identical
components (i.e., CBT) were administered under very
diverse conditions across studies: for example, in some
studies significant others were allowed to attend study ses-
sions or were also enrolled, adding a possible support
component. Relaxation techniques were used in most
studies in adjunct to the "major" intervention(s), but very
spare details were provided about these techniques,
despite their potential to offer relief. In the case of multi-
component interventions, it is impossible to determine
which component was effective, to what extent, and if it
had a cumulative effect. This issue is not merely academic,
since multi-component interventions using different pro-
viders are more expensive than self-administered ones.
Finally, studies did not provide details about standardiza-
tion of intervention delivery, i.e., attached scripts of the
phone conversations or support meetings, and did not
assess either patients' or providers' adherence to the inter-
vention. As in most behavioural interventions, blinding of
participants was impossible; attempts to blind outcome
assessors or care providers not involved in the study were
not mentioned.
Comparison group
Most studies (8/12) used a "usual care" comparison
group. According to the CONSORT[39] statement, infor-
mation about the usual care group allows the readers to
compare the experimental intervention with what is usu-
ally offered to patients as "regular" standard of care. Two
out of eight studies did not provide details about what
"usual care" would entail. When this information was
available, what was offered as "usual care" differed greatly
across studies (Additional File 3). This could have impor-
tant consequences on the assessment of the difference
between groups. Far from being "neutral", usual care
assignment does expose patients to some form of "treat-
ment": the more intense the treatment, the less the differ-
ence between the intervention and the control group.
Furthermore, a "usual care" comparison group may not
account for the additional attention received by the inter-
vention group. An "attention control" or "active control"
comparison group would be probably superior to usual
care because it controls for nonspecific treatment effects
that maybe associated with the intervention [57,58].
Confounders
Device
Earlier studies enrolled patients who underwent thoracot-
omy and received more bulky devices. The implantation
of such devices required a much longer and complex pro-
cedure than modern ICDs, possibly affecting pre-interven-
tion anxiety levels.
Number of shocks and time from implantation
Some studies included both patients who had received
previous shocks and those who had not. Psychological
distress is higher in patients receiving shocks [59,60].
Device discharges may act as an effect modifier, i.e. the
effect of the intervention may differ in patients who
received or did not receive shocks. Also, patients were
recruited at different times after ICD implantation, intro-
ducing the confounding factor of improved psychological
adaptation to ICD over time[8]. This factor may explain
the lack of effect among patients enrolled more than 1
year after ICD implantation [52,53].
Clinical characteristics
Data about the participants' clinical condition (e.g. NYHA
class) were not reported or were reported only at baseline;
thus, it is impossible to determine whether lower anxiety
scores are due to the intervention or to improvements in
the underlying cardiac condition. Likewise, not adjusting
for concomitant use of psychotropic and anti-arrhythmic
drugs prevents conclusions about the effect on cardiac
arrhythmias or shocks.
External Validity
The external validity of the studies was questionable. Most
recruiting centres were teaching hospitals or tertiary refer-
ral centres. Two of three studies adequately describing the
recruitment process reported that only 28% [44] and 26%
[46] of the screened population was enrolled in the study,
limiting generalizability.
Limitations of present review
This review has some limitations. First, we included only
articles in English published in peer-reviewed journals;
studies in other languages might offer different insights.
Second, due to the heterogeneous nature of the studies,
we only conducted a qualitative analysis.
Conclusions
Due to methodological limitations, more research is
needed to determine whether psychosocial interventions
relieve emotional distress in ICD patients. Future studies
should be designed as large-scale RCTs, with a longer (1-
year) follow up period. Considering the behavioural
nature of the interventions, an adequate description of the
intervention procedures and an assessment of patients'
adherence and providers' treatment fidelity are required.
Finally, baseline screening for anxiety and depression
would probably allow for the recruitment of patients with
significant psychological symptoms that are more likely to
benefit from the intervention.
In conclusion, the initial evidence for psychosocial inter-
ventions benefiting ICD patients needs to be confirmed
by further, methodologically rigorous, research that takes
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into account the specific challenges of evaluating the
effect of a behavioural intervention. Considering the
expanding indications for ICD implantation [2,3], the
number of ICD candidates and patients experiencing psy-
chological discomfort are destined to increase. Thus,
improving their psychological well-being seems worth-
while.
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